57 related articles for article (PubMed ID: 24397610)
1. Free energy simulations of binding of HsTx1 toxin to Kv1 potassium channels: the basis of Kv1.3/Kv1.1 selectivity.
Rashid MH; Kuyucak S
J Phys Chem B; 2014 Jan; 118(3):707-16. PubMed ID: 24397610
[TBL] [Abstract][Full Text] [Related]
2. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.
Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C
Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388
[TBL] [Abstract][Full Text] [Related]
3. KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers.
Szekér P; Bodó T; Klima K; Csóti Á; Hanh NN; Murányi J; Hajdara A; Szántó TG; Panyi G; Megyeri M; Péterfi Z; Farkas S; Gyöngyösi N; Hornyák P
J Biol Chem; 2024 Apr; 300(4):107155. PubMed ID: 38479597
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship exploration of Kv1.3 blockers based on diphenoxylate.
Nguyen W; Howard BL; Jenkins DP; Wulff H; Thompson PE; Manallack DT
Bioorg Med Chem Lett; 2012 Dec; 22(23):7106-9. PubMed ID: 23084278
[TBL] [Abstract][Full Text] [Related]
5. Cryo-EM structures of Kv1.2 potassium channels, conducting and non-conducting.
Wu Y; Yan Y; Yang Y; Bian S; Rivetta A; Allen K; Sigworth FJ
bioRxiv; 2024 Mar; ():. PubMed ID: 37398110
[TBL] [Abstract][Full Text] [Related]
6. Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver.
Wang Y; Hurley A; De Giorgi M; Tanner MR; Hu RC; Pennington MW; Lagor WR; Beeton C
PLoS One; 2023; 18(4):e0283996. PubMed ID: 37040361
[TBL] [Abstract][Full Text] [Related]
7. Probing pattern and dynamics of disulfide bridges using synthesis and NMR of an ion channel blocker peptide toxin with multiple diselenide bonds.
Fehér K; Timári I; Rákosi K; Szolomájer J; Illyés TZ; Bartok A; Varga Z; Panyi G; Tóth GK; Kövér KE
Chem Sci; 2016 Apr; 7(4):2666-2673. PubMed ID: 28660039
[TBL] [Abstract][Full Text] [Related]
8. Discovery of K
Gubič Š; Hendrickx LA; Toplak Ž; Sterle M; Peigneur S; Tomašič T; Pardo LA; Tytgat J; Zega A; Mašič LP
Med Res Rev; 2021 Jul; 41(4):2423-2473. PubMed ID: 33932253
[TBL] [Abstract][Full Text] [Related]
9. Structural Determinants Mediating Tertiapin Block of Neuronal Kir3.2 Channels.
Patel D; Kuyucak S; Doupnik CA
Biochemistry; 2020 Feb; 59(7):836-850. PubMed ID: 31990535
[TBL] [Abstract][Full Text] [Related]
10. Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats.
Bergmann R; Kubeil M; Zarschler K; Chhabra S; Tajhya RB; Beeton C; Pennington MW; Bachmann M; Norton RS; Stephan H
Sci Rep; 2017 Jun; 7(1):3756. PubMed ID: 28623364
[TBL] [Abstract][Full Text] [Related]
11. Molecular Simulations of Disulfide-Rich Venom Peptides with Ion Channels and Membranes.
Deplazes E
Molecules; 2017 Feb; 22(3):. PubMed ID: 28264446
[TBL] [Abstract][Full Text] [Related]
12. Biobetters From an Integrated Computational/Experimental Approach.
Kuyucak S; Kayser V
Comput Struct Biotechnol J; 2017; 15():138-145. PubMed ID: 28179976
[TBL] [Abstract][Full Text] [Related]
13. Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.
Nekrasova OV; Volyntseva AD; Kudryashova KS; Novoseletsky VN; Lyapina EA; Illarionova AV; Yakimov SA; Korolkova YV; Shaitan KV; Kirpichnikov MP; Feofanov AV
J Neuroimmune Pharmacol; 2017 Jun; 12(2):260-276. PubMed ID: 27640211
[TBL] [Abstract][Full Text] [Related]
14. Modeling of the Binding of Peptide Blockers to Voltage-Gated Potassium Channels: Approaches and Evidence.
Novoseletsky VN; Volyntseva AD; Shaitan KV; Kirpichnikov MP; Feofanov AV
Acta Naturae; 2016; 8(2):35-46. PubMed ID: 27437138
[TBL] [Abstract][Full Text] [Related]
15. Mapping the Interaction Anatomy of BmP02 on Kv1.3 Channel.
Wu B; Wu BF; Feng YJ; Tao J; Ji YH
Sci Rep; 2016 Jul; 6():29431. PubMed ID: 27403813
[TBL] [Abstract][Full Text] [Related]
16. Computational Studies of Glutamate Transporters.
Setiadi J; Heinzelmann G; Kuyucak S
Biomolecules; 2015 Nov; 5(4):3067-86. PubMed ID: 26569328
[TBL] [Abstract][Full Text] [Related]
17. Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region.
Xiang F; Xie Z; Feng J; Yang W; Cao Z; Li W; Chen Z; Wu Y
Toxins (Basel); 2015 Jan; 7(1):34-42. PubMed ID: 25568977
[TBL] [Abstract][Full Text] [Related]
18. Systematic study of binding of μ-conotoxins to the sodium channel NaV1.4.
Mahdavi S; Kuyucak S
Toxins (Basel); 2014 Dec; 6(12):3454-70. PubMed ID: 25529306
[TBL] [Abstract][Full Text] [Related]
19. Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeutics.
Kuyucak S; Norton RS
Future Med Chem; 2014 Oct; 6(15):1645-58. PubMed ID: 25406005
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
